GoldenGolden
Natera

Natera

A company developing tests for pre-implantation genetic diagnosis for IVF and non-invasive prenatal test

Natera specializes in providing DNA testing across multiple clinical areas including women's health, organ health, and oncology through a cell-free DNA (cfDNA) technology platform approach.

Timeline

April 2015
Natera raises a $55,500,000 series F round from Franklin Templeton Investments, HealthCor Partners, Jennison Associates, OrbiMed, RA Capital Management, Sequoia Capital and Sofinnova Investments.
May 2013
Natera raises a $54,600,000 series E round from Claremont Creek Ventures, Founders Fund, Harmony Partners, Lightspeed Venture Partners, OrbiMed and Sequoia Capital.
January 6, 2012
Natera raises a $20,000,000 series D round from Claremont Creek Ventures, Lightspeed Venture Partners and Sequoia Capital.
April 2011
Natera raises a $2,000,000 grant from National Institutes of Health.
November 2010
Natera raises a $12,000,000 series C round from Sequoia Capital.
January 2009
Natera raises a $6,000,000 series B round from Alafi Capital, Claremont Creek Ventures and Sequoia Capital.
December 2008
Natera raises a $4,000,000 series A round from Claremont Creek Ventures and Sequoia Capital.
2007
Natera was founded by Jonathan Sheena and Matthew Rabinowitz.

Funding rounds

Funding round
Funding type
Funding round amount (USD)
Funding round date
Investment
Natera Series F round, April 2015
55,500,000
April 2015
9 Results
Results per page:
Page 1 of 1

People

Name
Role
LinkedIn

Agnes Fajardo

Employee

Agust Egilsson

Employee

AJ Errickson

Employee

Akshita Kalyan

Employee

Alana Anderson

Employee

Alana Turangan

Employee

Albert Chan, MD

Advisor

Alex Wong

Employee

Alfred Haddad

Employee

Amanda Yang

Employee

Amy Johnson

Employee

Andrew Anfora

Employee

Andy Shinn

Employee

Angela Chu

Employee

Ann-Marie Soto

Employee

Annabelle Tang

Employee

Archana Dorge

Employee

Audrey Mark

Employee

Bobbi Ratley

Employee

Brandon Nguyen

Employee

Brandon Rader

Employee

Brian Johnson

Employee

Bronwyn Barnett

Employee

Caroline Kelly

Employee

Catherine Medina

Employee

Page 1 of 5

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

News

Title
Author
Date
Publisher
Description
Natera, Inc.
May 3, 2021
www.prnewswire.com:443
/PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, today announced it will present 4 posters at the 2021...
Natera, Inc.
April 29, 2021
www.prnewswire.com:443
/PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, today announced that it will release results for its first...
April 22, 2021
BioSpace
ProsperaTM Transplant Assessment Test: Path Established to Expand Future Coverage to Multiple Organs - read this article along with other careers information, tips and advice on BioSpace
Natera, Inc.
April 22, 2021
www.prnewswire.com:443
/PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a pioneer and a global leader in cell-free DNA testing, receives pathway to future coverage for the Prospera...
Natera, Inc.
February 11, 2021
www.prnewswire.com:443
/PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, today announced that Alexey Aleshin, MD, Natera's Senior...
Natera, Inc.
February 1, 2021
www.prnewswire.com:443
/PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cfDNA testing, presented key results from its SMART study at the SMFM 41st Annual...
Natera, Inc.
January 20, 2021
www.prnewswire.com:443
/PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, filed a lawsuit today against Inivata, Ltd. and its...
Natera, Inc.
January 14, 2021
www.prnewswire.com:443
/PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA (cfDNA) testing, today announced it will present new data on the...
Natera, Inc.
January 12, 2021
www.prnewswire.com:443
/PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, today announced it will present new data on its personalized...
Natera, Inc.
January 5, 2021
www.prnewswire.com:443
/PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, today announced that it will webcast a live presentation at...
Natera, Inc.
December 18, 2020
www.prnewswire.com:443
/PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA (cfDNA) testing, is pleased that the United States Patent Office...
Natera, Inc.
December 3, 2020
www.prnewswire.com:443
/PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, today announced that the second largest commercial health...
Natera, Inc.
November 30, 2020
www.prnewswire.com:443
/PRNewswire/ -- Natera,Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, today announced a new paper published in Annals of Oncology,...
BioSpace
November 19, 2020
BioSpace
Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, today announced that it has appointed Dr. Monica Bertagnolli to its board of directors.
Natera, Inc.
November 10, 2020
www.prnewswire.com:443
/PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, today announced it will present new immunotherapy data on...
BioSpace
June 1, 2020
BioSpace
Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, is pleased to announce the launch of a novel technique to enhance results from the Prospera donor-derived cell-free DNA (dd-cfDNA) transplant reject
Natera
May 6, 2019
www.prnewswire.com:443
SAN CARLOS, Calif., May 6, 2019 /PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA) today announced that the U.S. Food and Drug Administration (FDA) has granted...
Natera
April 16, 2019
www.prnewswire.com:443
SAN CARLOS, Calif., April 16, 2019 /PRNewswire/ -- Natera, Inc. (Nasdaq: NTRA), a global leader in cell-free DNA testing, today announced the launch of a...

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.